Nicole Gaudelli PhD

Beam Therapeutics

Appearances

An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein
Date
March 9, 2021
Speaker
Nicole Gaudelli, PhD
Beam Therapeutics
Therapeutics I: Ex Vivo Editing
Date
March 9, 2021
Co-Chairs
Rachel E. Haurwitz, PhD
Caribou Biosciences, Inc.
Nicole Gaudelli, PhD
Beam Therapeutics

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.

Nicole Gaudelli PhD

Beam Therapeutics

Appearances

An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein

Speaker

Therapeutics I: Ex Vivo Editing

Co-Chairs